Cisplatin Injection
Product Images NDC 68001-283

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cisplatin (NDC 68001-283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\departments\bplabs\quality & Regulatory\regulatory\artwork Files Bluepoint\intas Pharmaceuticals Limited Artwork\cisplatin Injection\approved\cisplatin Injection 100ml Carton Rev 03_16.jpg (Cisplatin Inj 100mg Carton)

Cisplatin Injection 1 mg/mL (100 mg/100 mL) intravenous solution carton label from BluePoint Laboratories. The label includes warnings for cytotoxicity, storage instructions to keep between 20°C to 25°C, and notes on pH adjustment and storage precautions. It states the product is sterile, multiple dose, and contains details about manufacturer and packaging.*

FDA Label Image

S:\departments\bplabs\quality & Regulatory\regulatory\artwork Files Bluepoint\intas Pharmaceuticals Limited Artwork\cisplatin Injection\approved\cisplatin Injection 100ml Label Rev 03_16.jpg (Cisplatin Inj 100mg Label)

Label for Cisplatin Injection 1 mg/mL (100 mg/100 mL) sterile intravenous solution by BluePoint Laboratories. The label includes dosage form, active ingredient strength, storage instructions, manufacturer details (Intas Pharmaceuticals Limited, India), and warnings including 'Cytotoxic Agent' and dosage cautions. The label also features barcodes and revision date 06/2019.*

FDA Label Image

S:\departments\bplabs\quality & Regulatory\regulatory\artwork Files Bluepoint\intas Pharmaceuticals Limited Artwork\cisplatin Injection\approved\cisplatin Injection 50ml Carton Rev 03_16.jpg (Cisplatin Inj 50mg Carton)

Cisplatin injection 50 mg/50 mL (1 mg/mL) sterile intravenous solution by BluePoint Laboratories. The label includes warnings about cytotoxicity and dosage limits for Cisplatin doses exceeding 100 mg/m². It lists storage instructions, manufacturing details from Intas Pharmaceuticals Limited, and cautions not to refrigerate or freeze the solution.*

FDA Label Image

S:\departments\bplabs\quality & Regulatory\regulatory\artwork Files Bluepoint\intas Pharmaceuticals Limited Artwork\cisplatin Injection\approved\cisplatin Injection 50ml Label Rev 03_16.jpg (Cisplatin Inj 50mg Label)

Cisplatin Injection 1 mg/mL in a 50 mg/50 mL multiple dose vial label from BluePoint Laboratories. The sterile solution is for intravenous use, with a caution warning for cytotoxicity. The label includes storage instructions and manufacturer details, showing it is made by Intas Pharmaceuticals Limited in India for BluePoint Laboratories.*

FDA Label Image

Chemical Structure (Cisplatin Structure)

Chemical structure of cisplatin showing a central platinum atom bonded to two chlorine atoms and two ammonia (NH3) groups in a square planar configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.